Lei Deng, MD
University of Washington/Fred Hutch Cancer Center
Faculty
Financial Disclosure
Bristol Myers Squibb, Regeneron, Boehringer Ingelheim
Consultant
BridgeBio Oncology Therapeutics, Merck, Solve Therapeutics, Bristol Myers Squibb, BillionToOne, Revolution Medicines, Daiichi Sankyo
Grant Or Contract
MJH Life Science, PrecisCa, DAVA Oncology, Curio Science, CardinalHealth, IDEOlogy Health, Curta, Binaytara Foundation, Total Health
Professional Service